Old Articles: <Older 8891-8900 Newer> |
|
Chemistry World July 25, 2014 Anthony King |
Pharma firms rush to escape US tax shackles US drug company AbbVie has persuaded Hampshire-based, Irish-headquartered Shire to enter a mega-merger. The enlarged firm will cut its US tax bill. |
Fast Company Sindya N. Bhanoo |
When Wearable Tech Saves Your Life, You Won't Take It Off A small cadre of companies has been furiously working to develop smaller, sleeker, more discreet devices that monitor health and wellness -- in the form of temporary tattoos, band-aids, and ingestible pills. |
Chemistry World July 11, 2014 Phillip Broadwith |
Co-operation keeps contracts coming A group of specialist companies based in and around Nottingham's BioCity small business incubator can offer a more comprehensive suite of services. |
Pharmaceutical Executive July 10, 2014 Fitzpatrick & Mohan |
Vaccines: Fire in the Cold Chain It's only recently that vaccine producers experienced the commercial returns commensurate with vaccines: long record of positive public health performance. |
Pharmaceutical Executive July 10, 2014 Ben Comer |
WebMD: The Patient Value Equation For WebMD CEO David Schlanger, connecting patients with physicians through a robust digital platform delivers the winning formula necessary to achieve quality of care, cost savings, and better health outcomes. |
Pharmaceutical Executive July 10, 2014 William Looney |
Pharm Exec's 2014 Dealmakers Outlook As the pacing picks up around dealmaking as the alternative to organic growth, Pharm Exec brings together experts from big Pharma and biotech to dissect the road ahead. |
Pharmaceutical Executive July 10, 2014 Ben Comer |
FDA Spread Thinly Abroad Is FDA capable of sufficiently overseeing global drug imports? |
Pharmaceutical Executive July 10, 2014 William Looney |
BIO 2014 Takeaway: The Peace Dividend A surprising takeaway from the recent BIO International Convention is the stark contrast between cooperative industry engagement and an unstable geopolitical order. |
Pharmaceutical Executive July 1, 2014 |
Country Report: Poland Poland's pharma industry, the largest in Central and Eastern Europe, confronts the fallout from the government's controversial 2012 Reimbursement Act. |
Pharmaceutical Executive July 1, 2014 Allen Gove |
Capturing the Real Value from a Pharma Business Spinout As companies divest non-core assets in the form of spinouts to unlock value, the role of a strong new parent brand has become increasingly important. |
<Older 8891-8900 Newer> Return to current articles. |